Mark Kleinewietfeld, Kirsten Falk and Dr. Tzschke the Max Delbr? Ck Center for Molecular Medicine Berlin-Buch, Germany, and their colleagues from the Fondazione Santa Lucia in Rome, Italy a simple method a simple method to develop these cells from human blood. Doi 10 1182/blood-2008-04 – 150524)*.. But until nowor immunotherapy for patients with leukemiaIn the future, bone marrow transfer to patients with leukemia be safer. Experiments in mice have already been that certain cells of the immune system to the dangerous side effects from the treatment incurred suppress shown.
In other markers , the scientists have succeeded in separating the aggressive and dangerous immune cells from the helpful, regulatory cells. So it is now possible graft-versus – safe isolation in high purity from human blood. T cells T cells, the researchers were able to suppress a particular severe form of the graft-versus – host disease ‘ in mice. In an initial clinical trial in Singapore, the MDC researchers now want the regulatory cells in leukemia patients, shall developed severe immune response after a bone marrow donation.Global Ovarian Day was founded in 2008 increase as part of of a campaign that organized by the European Thyroid Association , and of the American Thyroid Association to stress the prevalence of thyroid cancer, the urgent need to the urgent need for formation and prevention programs and conscious founded in new methods of treatment.